These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 19098283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
    Liu CY, Broadhurst R, Marcovina SM, McCormick SP.
    J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly.
    Dardik BN, Schwartzkopf CD, Stevens DE, Chatelain RE.
    J Lipid Res; 2000 Jun; 41(6):1013-9. PubMed ID: 10828094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR, Koschinsky ML.
    Biochemistry; 1998 May 26; 37(21):7892-8. PubMed ID: 9601051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly.
    Sharp RJ, Perugini MA, Marcovina SM, McCormick SP.
    J Lipid Res; 2004 Dec 26; 45(12):2227-34. PubMed ID: 15375179
    [Abstract] [Full Text] [Related]

  • 12. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E, Graham MJ, Mullick AE, Miller ER, Crooke RM, Pitas RE, Witztum JL, Tsimikas S.
    Circulation; 2008 Aug 12; 118(7):743-53. PubMed ID: 18663084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A synthetic peptide that inhibits lipoprotein(a) assembly.
    Sharp RJ, Perugini MA, Marcovina SM, McCormick SP.
    Arterioscler Thromb Vasc Biol; 2003 Mar 01; 23(3):502-7. PubMed ID: 12615683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
    Callow MJ, Rubin EM.
    J Biol Chem; 1995 Oct 13; 270(41):23914-7. PubMed ID: 7592581
    [Abstract] [Full Text] [Related]

  • 17. Quantification of apo[a] and apoB in human atherosclerotic lesions.
    Pepin JM, O'Neil JA, Hoff HF.
    J Lipid Res; 1991 Feb 13; 32(2):317-27. PubMed ID: 1829751
    [Abstract] [Full Text] [Related]

  • 18. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
    Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM.
    Proc Natl Acad Sci U S A; 1994 Mar 15; 91(6):2130-4. PubMed ID: 8134359
    [Abstract] [Full Text] [Related]

  • 19. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM.
    Hum Gene Ther; 1996 Jan 15; 7(1):39-49. PubMed ID: 8825867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.